| 000 | 01456 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516143357.0 | ||
| 264 | 0 | _c20151006 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1758-1125 | ||
| 024 | 7 |
_a10.1177/0268355513483280 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRabe, E | |
| 245 | 0 | 0 |
_aEuropean guidelines for sclerotherapy in chronic venous disorders. _h[electronic resource] |
| 260 |
_bPhlebology _cJul 2014 |
||
| 300 |
_a338-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Practice Guideline | ||
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPolidocanol |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
| 650 | 0 | 4 |
_aSclerosing Solutions _xadverse effects |
| 650 | 0 | 4 |
_aSclerotherapy _xmethods |
| 650 | 0 | 4 | _aSocieties, Medical |
| 650 | 0 | 4 |
_aSodium Tetradecyl Sulfate _xtherapeutic use |
| 650 | 0 | 4 |
_aVaricose Veins _xtherapy |
| 700 | 1 | _aBreu, F X | |
| 700 | 1 | _aCavezzi, A | |
| 700 | 1 | _aColeridge Smith, P | |
| 700 | 1 | _aFrullini, A | |
| 700 | 1 | _aGillet, J L | |
| 700 | 1 | _aGuex, J J | |
| 700 | 1 | _aHamel-Desnos, C | |
| 700 | 1 | _aKern, P | |
| 700 | 1 | _aPartsch, B | |
| 700 | 1 | _aRamelet, A A | |
| 700 | 1 | _aTessari, L | |
| 700 | 1 | _aPannier, F | |
| 773 | 0 |
_tPhlebology _gvol. 29 _gno. 6 _gp. 338-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0268355513483280 _zAvailable from publisher's website |
| 999 |
_c22643954 _d22643954 |
||